News Details

HCA Holdings, Inc. (NYSE: HCA) today announced financial and operating results for the second quarter ended June 30, 2015.

Key second quarter metrics (all percentage changes compare 2Q 2015 to 2Q 2014 unless noted):

• Revenues increased 7.2 percent to $9.897 billion
• Net income attributable to HCA Holdings, Inc. totaled $507 million, or $1.18 per diluted share
• Net income per diluted share excluding losses on sales of facilities and losses on retirement of debt, was $1.37 per diluted share for 2Q 2015
• Adjusted EBITDA totaled $2.008 billion
• Cash flows from operations totaled $1.057 billion
• Same facility equivalent admissions increased 4.9 percent while same facility admissions increased 4.1 percent
• Same facility revenue per equivalent admission increased 1.2 percent
• Same facility revenue per equivalent admission increased 2.8 percent, after excluding from revenues the $142 million Texas Medicaid Waiver adjustment in 2Q 2014

Revenues in the second quarter increased to $9.897 billion, compared to $9.230 billion in the second quarter of 2014. Net income attributable to HCA Holdings, Inc. totaled $507 million, or $1.18 per diluted share, compared to $483 million, or $1.07 per diluted share, in the second quarter of 2014. Adjusted EBITDA totaled $2.008 billion compared to $2.000 billion in the second quarter of 2014. Adjusted EBITDA is a non-GAAP financial measure. A table reconciling net income attributable to HCA Holdings, Inc. to Adjusted EBITDA is included in this release.

The second quarter 2015 results include losses on retirement of debt of $125 million, or $0.18 per diluted share, and losses on sales of facilities of $5 million, or $0.01 per diluted share. Second quarter 2014 results include losses on retirement of debt of $226 million, or $0.32 per diluted share, and gains on sales of facilities of $11 million, or $0.02 per diluted share. The second quarter 2014 results also include a $142 million, or $0.20 per diluted share, adjustment to increase Medicaid revenues related to the receipt of reimbursements in excess of our estimates for the indigent care component of the Texas Medicaid Waiver Program for the program year ended September 30, 2013.

Same facility admissions for the second quarter of 2015 increased 4.1 percent, while same facility equivalent admissions increased 4.9 percent. Same facility emergency room visits for the second quarter of 2015 increased 7.4 percent from the prior year’s second quarter. Same facility inpatient surgeries increased 2.0 percent while same facility outpatient surgeries increased 1.0 percent compared to the prior year.

Same facility revenue per equivalent admission increased 1.2 percent for the second quarter of 2015. Same facility revenue per equivalent admission increased 2.8 percent in the second quarter of 2015 compared to the prior year’s second quarter, after adjusting second quarter 2014 revenues to exclude the impact of the $142 million adjustment to increase revenues related to the Texas Medicaid Waiver Program.

During the second quarter of 2015, salaries and benefits, supplies and other operating expenses totaled $7.917 billion, or 80.0 percent of revenues, compared to $7.274 billion, or 78.8 percent of revenues, in the second quarter of 2014.

Six Months Ended June 30, 2015

Revenues for the six months ended June 30, 2015 totaled $19.573 billion compared to $18.062 billion in the same period of 2014. Net income attributable to HCA Holdings, Inc. was $1.098 billion, or $2.54 per diluted share, compared to $830 million, or $1.82 per diluted share, for the first six months of 2014. Results for the six months ended June 30, 2015 include gains on sales of facilities of $4 million and losses on retirement of debt of $125 million, or $0.18 per diluted share. Results for the six months ended June 30, 2014 include gains on sales of facilities of $32 million, or $0.04 per diluted share, losses on retirement of debt of $226 million, or $0.31 per diluted share, and legal claim costs of $78 million, or $0.11 per diluted share. The second quarter of 2014 results also includes a $142 million, or $0.20 per diluted share, adjustment to increase revenues associated with the Texas Medicaid Waiver Program.

Balance Sheet and Cash Flows from Operations

As of June 30, 2015, HCA Holdings, Inc.’s balance sheet reflected cash and cash equivalents of $673 million, total debt of $29.737 billion, and total assets of $31.710 billion. During the second quarter of 2015, capital expenditures totaled $558 million, excluding acquisitions. Cash flows provided by operating activities in the quarter totaled $1.057 billion compared to $1.250 billion in the second quarter of 2014. The $193 million decline in cash flows from operating activities related primarily to increases in income tax payments in the second quarter of 2015.

As of June 30, 2015, HCA’s leverage ratio as measured by Total Debt/Adjusted EBITDA was 3.84x, compared to 3.96x as of December 31, 2014.

During the second quarter of 2015, the Company repurchased $574 million, or 7,346,850 shares of its common stock and through June 30, 2015, has repurchased $940 million, or 12,552,244 shares of its common stock. The Company had $1.060 billion remaining under its existing repurchase authorizations as of June 30, 2015.

As of June 30, 2015, HCA operated 168 hospitals and 112 freestanding surgery centers.

2015 Guidance

The Company now anticipates Adjusted EBITDA and Adjusted EPS for the year ending December 31, 2015, to be near the high-end of its previously issued guidance range of $7.55 to $7.85 billion and $4.90 - $5.30 per diluted share, respectively.

The Company’s 2015 guidance contains a number of assumptions, including:

• The Company estimates approximately 6 to 7 percent of Adjusted EBITDA would be attributable to the Patient Protection and Affordable Care Act (Health Reform Law);
• EHR incentive income of $40-$50 million and EHR expenses in a range of $30-$40 million, as compared to EHR incentive income of $125 million and EHR expenses of $112 million in 2014;
• Completion of $1 billion share repurchase authorized in February 2015, but does not include repurchases under the additional $1.0 billion authorized in May 2015;
• An increase in share-based compensation expense to approximately $224 million from $163 million in 2014;
• Guidance excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claim costs and impairments of long-lived assets;
• Guidance does not include any anticipated contribution in 2015 from certain items which impacted 2014 Adjusted EBITDA, including: (i) a $142 million increase to Medicaid revenues reflecting payments in excess of our estimates for the indigent care component of the Texas Medicaid Waiver Program for the program year ended September 30, 2013, and recorded in the 2^nd quarter of 2014, and (ii) $90 million in Medicare revenues recorded in 3Q 2014 in settlement for certain claims denied by Recovery Audit Contractors (“RAC”); and
• Guidance no longer assumes a $70 million reduction in Medicaid revenues related to the Texas Medicaid Waiver Program.

Earnings Conference Call

HCA will host a conference call for investors at 9:00 a.m. Central Daylight Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed at: https://event.webcasts.com/starthere.jsp?ei=1070626 or through the Company’s Investor Relations web page, www.hcahealthcare.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include statements that do not relate solely to historical or current facts. Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, (1) the impact of our substantial indebtedness and the ability to refinance such indebtedness on acceptable terms, (2) the effects related to the implementation of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the “Health Reform Law”), possible delays in or complications related to implementation of the Health Reform Law, court challenges, the possible enactment of additional federal or state health care reforms and possible changes to the Health Reform Law and other federal, state or local laws or regulations affecting the health care industry, (3) the effects related to the continued implementation of the sequestration spending reductions required under the Budget Control Act of 2011 (the “BCA”), and related legislation extending these reductions, and the potential for future deficit reduction legislation that may alter these spending reductions, which include cuts to Medicare payments, or create additional spending reductions, (4) increases in the amount and risk of collectability of uninsured accounts and deductibles and copayment amounts for insured accounts, (5) the ability to achieve operating and financial targets, and attain expected levels of patient volumes and control the costs of providing services, (6) possible changes in Medicare, Medicaid and other state programs, including Medicaid upper payment limit programs or waiver programs, that may impact reimbursements to health care providers and insurers, (7) the highly competitive nature of the health care business, (8) changes in service mix, revenue mix and surgical volumes, including potential declines in the population covered under managed care agreements, the ability to enter into and renew managed care provider agreements on acceptable terms and the impact of consumer driven health plans and physician utilization trends and practices, (9) the efforts of insurers, health care providers and others to contain health care costs, (10) the outcome of our continuing efforts to monitor, maintain and comply with appropriate laws, regulations, policies and procedures, (11) increases in wages and the ability to attract and retain qualified management and personnel, including affiliated physicians, nurses and medical and technical support personnel, (12) the availability and terms of capital to fund the expansion of our business and improvements to our existing facilities, (13) changes in accounting practices, (14) changes in general economic conditions nationally and regionally in our markets, (15) the emergence and effects related to infectious diseases, including Ebola; (16) future divestitures which may result in charges and possible impairments of long-lived assets, (17) changes in business strategy or development plans, (18) delays in receiving payments for services provided, (19) the outcome of pending and any future tax audits, disputes and litigation associated with our tax positions, (20) potential adverse impact of known and unknown government investigations, litigation and other claims that may be made against us, (21) our ongoing ability to demonstrate meaningful use of certified electronic health record technology and recognize income for the related Medicare or Medicaid incentive payments, and (22) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2014 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

All references to “Company” and “HCA” as used throughout this release refer to HCA Holdings, Inc. and its affiliates.

HCA Holdings, Inc.
Investor Contact:
Mark Kimbrough, 615-344-2688
or
Media Contact:
Ed Fishbough, 615-344-2810